Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma
Clinical trial NCT07316010 · RECRUITING
Trial details
- NCT number
- NCT07316010
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-17
- Primary completion
- 2029-03-21
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.